Longevity Research Hub

Evidence-based longevity research: GLP-1, NAD+, rapamycin, Bryan Johnson protocols and healthspan tools. Plain-English, no hype.

Tools & hubs

Longevity Research Hub 2026 — Evidence-Based Healthspan GuideComprehensive longevity research: what actually works in 2026. Rapamycin, NMN, GLP-1, epigenetic clocks, lifestyle protocols. Science-backed, no hype.AI Longevity Protocol Generator — Personalized Evidence-Based StackGenerate your personalized longevity protocol in 60 seconds. AI synthesizes 2026 research and builds a custom supplement + lifestyle plan based on your age, goals...

Articles

GLP-1 + Longevity: Why Semaglutide May Add Years to Your Life (2026 Data)Semaglutide longevity research 2026: SELECT trial shows 20% cardiovascular death reduction, new mTORC1 autophagy data, VITAL-H trial comparing semaglutide vs...Bryan Johnson Drops Rapamycin: What He's Using Instead (March 2026)Bryan Johnson officially dropped rapamycin from his Blueprint protocol in March 2026 due to hair loss, wound healing issues, and metabolic side effects.Rapamycin's Cardiovascular Benefits: What the 2025-2026 Human Trials RevealNew human trial data (GeroScience 2025, PEARL Trial 2025) confirms rapamycin's cardiovascular benefits at low doses. What longevity enthusiasts need to know in 2026.NAD+ and NMN in 2026: What the Latest Science Actually SaysNature Aging (March 2026) reviewed NAD+ for Alzheimer's, Parkinson's, and aging. Here's what 25+ scientists found — and the practical protocol based on the evidence.NAD+ Supplementation in 2026: What the Latest Research SaysA Nature Aging review by 25+ scientists (March 2026) just changed what we know about NAD+. Here's what the latest research says — and how to apply it practically.Build Your Personalized Longevity Protocol in 2026: The Evidence-Based ApproachHow to build a personalized longevity protocol in 2026 based on your age, goals, and budget.The $22M Government Bet on Slowing Human AgingARPA-H just awarded $22M to test Censavudine in 200 adults aged 60-65. It's the first major US federal investment in a dedicated healthspan trial.
Informational content only. Not medical advice; consult a physician before starting any supplement or prescription protocol.

Looking for our AI automation services? See what ABC AI Lab builds or browse the AI automation blog.